BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33332686)

  • 21. A molecular graded prognostic assessment (molGPA) model specific for estimating survival in lung cancer patients with leptomeningeal metastases.
    Yin K; Li YS; Zheng MM; Jiang BY; Li WF; Yang JJ; Tu HY; Zhou Q; Zhong WZ; Yang XN; Chen HJ; Yan HH; Li LL; Wu YL; Zhang XC
    Lung Cancer; 2019 May; 131():134-138. PubMed ID: 31027690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leptomeningeal metastasis from gynecologic cancers diagnosed by brain MRI.
    Toyoshima M; Tsuji K; Shigeta S; Tokunaga H; Ito K; Watanabe Y; Yoshinaga K; Otsuki T; Niikura H; Yaegashi N
    Clin Imaging; 2017; 41():42-47. PubMed ID: 27764719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Utility of Cerebrospinal Fluid Cell-Free DNA as Liquid Biopsy for Leptomeningeal Metastases in ALK-Rearranged NSCLC.
    Zheng MM; Li YS; Jiang BY; Tu HY; Tang WF; Yang JJ; Zhang XC; Ye JY; Yan HH; Su J; Zhou Q; Zhong WZ; Yang XN; Guo WB; Chuai S; Zhang Z; Chen HJ; Wang Z; Liu C; Wu YL
    J Thorac Oncol; 2019 May; 14(5):924-932. PubMed ID: 30659989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantifying cervical spondylosis: reliability testing of a coherent CT-based scoring system.
    Rydman E; Bankler S; Ponzer S; Järnbert-Pettersson H
    BMC Med Imaging; 2019 May; 19(1):45. PubMed ID: 31146696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MR imaging of mouse leptomeningeal metastases.
    Brandsma D; Taphoorn MJ; Reijneveld JC; Nas TM; Voest EE; Nicolay K; Blezer E
    J Neurooncol; 2004 Jun; 68(2):123-30. PubMed ID: 15218948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis.
    Freilich RJ; Krol G; DeAngelis LM
    Ann Neurol; 1995 Jul; 38(1):51-7. PubMed ID: 7611725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic Reliability of Leptomeningeal Disease Using Magnetic Resonance Imaging.
    Harris P; Diouf A; Guilbert F; Ameur F; Letourneau-Guillon L; Ménard C; Masucci L; Bélair M; Roberge D
    Cureus; 2019 Apr; 11(4):e4416. PubMed ID: 31245204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.
    Lee JS; Melisko ME; Magbanua MJ; Kablanian AT; Scott JH; Rugo HS; Park JW
    Breast Cancer Res Treat; 2015 Nov; 154(2):339-49. PubMed ID: 26520840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of leptomeningeal metastases in pediatrics.
    Chamberlain MC
    J Child Neurol; 1995 May; 10(3):191-9. PubMed ID: 7642887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI sequences and interslice gap influence leptomeningeal metastasis detection in children with brain tumors.
    Harreld JH; Khan A; Angel J; Han Y; Li Y; Gajjar A; Patay Z
    Neuroradiology; 2022 Jul; 64(7):1447-1456. PubMed ID: 35344053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leptomeningeal metastasis.
    Chamberlain MC
    Curr Opin Neurol; 2009 Dec; 22(6):665-74. PubMed ID: 19738466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The reliability of computed tomography and magnetic resonance imaging grading of lumbar facet arthropathy in total disc replacement patients.
    Stieber J; Quirno M; Cunningham M; Errico TJ; Bendo JA
    Spine (Phila Pa 1976); 2009 Nov; 34(23):E833-40. PubMed ID: 19927089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical characteristic and prognostic factors of leptomeningeal metastasis in patients with non-small-cell lung cancer-a retrospective study from one single cancer institute.
    Yan W; Jing W; An N; Tian Y; Guo D; Kong L; Zhu H; Yu J
    Cancer Med; 2019 Jun; 8(6):2769-2776. PubMed ID: 30993909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of agreement of cervical spine degenerative pathology findings in magnetic resonance imaging studies.
    Fu MC; Webb ML; Buerba RA; Neway WE; Brown JE; Trivedi M; Lischuk AW; Haims AH; Grauer JN
    Spine J; 2016 Jan; 16(1):42-8. PubMed ID: 26291398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal treatment of leptomeningeal spread in glioblastoma: analysis of risk factors and outcome.
    Noh JH; Lee MH; Kim WS; Lim DH; Kim ST; Kong DS; Nam DH; Lee JI; Seol HJ
    Acta Neurochir (Wien); 2015 Apr; 157(4):569-76. PubMed ID: 25663100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance imaging of leptomeningeal metastases to the spine.
    Chua SL; Goh PS; Tan LK
    Singapore Med J; 1993 Jun; 34(3):253-6. PubMed ID: 8266185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe.
    Le Rhun E; Rudà R; Devos P; Hoang-Xuan K; Brandsma D; Pérez Segura P; Soffietti R; Weller M
    J Neurooncol; 2017 Jun; 133(2):419-427. PubMed ID: 28455788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leptomeningeal Metastasis in a Breast Cancer Treated with Two Lines of Intrathecal Chemotherapy - a Case Report.
    Mikudova V; Rejlekova K; Gyarfas J; Oravcova I; Chovanec M; Mardiak J; Mego M
    Klin Onkol; 2019; 32(2):139-142. PubMed ID: 30995855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CSF levels of growth factors and plasminogen activators in leptomeningeal metastases.
    van de Langerijt B; Gijtenbeek JM; de Reus HP; Sweep FC; Geurts-Moespot A; Hendriks JC; Kappelle AC; Verbeek MM
    Neurology; 2006 Jul; 67(1):114-9. PubMed ID: 16832089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unique genomic profiles obtained from cerebrospinal fluid cell-free DNA of non-small cell lung cancer patients with leptomeningeal metastases.
    Ying S; Ke H; Ding Y; Liu Y; Tang X; Yang D; Li M; Liu J; Yu B; Xiang J; Mao X; Han-Zhang H; Hu W; Chen L
    Cancer Biol Ther; 2019; 20(4):562-570. PubMed ID: 30395779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.